Home » Topics » BioWorld Science

BioWorld Science
RSS

TRACON presents safety data review results for ENVASARC pivotal trial of envafolimab

Aug. 10, 2021

Allena initiates two phase II trials of its engineered urate oxidase, ALLN-346

Aug. 10, 2021

Response rate shows potential of ficlatuzumab with chemotherapy in treating AML

Aug. 9, 2021

AstraZeneca starts phase II SOLANO study of AZD-8233

Aug. 9, 2021

Initiation of phase I/II clinical trial of AK-117 in patients with AML

Aug. 9, 2021

Atridia initiates phase I study of SHR-1905

Aug. 9, 2021

Signal peptide peptidase-like 2B has a pathogenic role in Alzheimer's disease

Aug. 9, 2021

Enrollment ongoing in phase II study of USB-002 for respiratory distress due to COVID-19

Aug. 9, 2021

Antengene and MindRank AI collaborate to advance difficult-to-drug molecular targets

Aug. 9, 2021

Phase II study of ASC-40 for the treatment of acne vulgaris approved in China

Aug. 9, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 3, 2026